AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 257: H1228-H1234, 1989;
0363-6135/89 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wallace, A. W.
Right arrow Articles by Shoukas, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wallace, A. W.
Right arrow Articles by Shoukas, A. A.

AJP - Heart and Circulatory Physiology, Vol 257, Issue 4 1228-H1234, Copyright © 1989 by American Physiological Society


ARTICLES

Effects of vasopressin on pulmonary and systemic vascular mechanics

A. W. Wallace, C. M. Tunin and A. A. Shoukas
Department of Biomedical Engineering, Johns Hopkins Medical School, Baltimore, Maryland 21205.

The direct effects of vasopressin on the resistance and capacitance properties of the pulmonary and systemic vasculature were studied in nine aneural dogs on systemic and pulmonary bypass. The systemic and pulmonary pressure-flow, the systemic and pulmonary arterial pressure-volume, and the systemic and pulmonary venous pressure-volume relationships were determined for five levels of infused vasopressin. Vasopressin levels of approximately 10, 30, 150, 300, and 500 pg/ml were achieved by intravenous infusions. Samples of venous blood were drawn before and after each set of pressure-flow and pressure-volume relationships for the determination of vasopressin level by radioimmunoassay. A linear relationship was found between vasopressin level and systemic vascular resistance. Systemic vascular resistance increased 0.072 +/- 0.011 mmHg.kg.min.ml-1 for a change in vasopressin level of 100 pg/ml. Vasopressin did not affect pulmonary vascular resistance or any vascular compliance. High doses of infused arginine vasopressin were necessary to elicit substantial vasoconstriction.


This article has been cited by other articles:


Home page
ChestHome page
C. L. Holmes, B. M. Patel, J. A. Russell, and K. R. Walley
Physiology of Vasopressin Relevant to Management of Septic Shock
Chest, September 1, 2001; 120(3): 989 - 1002.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. F. Rothe and R. Maass-Moreno
Active and passive liver microvascular responses from angiotensin, endothelin, norepinephrine, and vasopressin
Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1147 - H1156.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online